Clinical Trial Information

Hello, this is the BD Team from Intoinworld. We’ve been steadily posting articles over time, but it looks like we’ve never really touched on the fundamentals: what exactly a CRO company is...

When foreign pharmaceutical companies prepare to enter the Korean market, the first barrier is not just language differences. A bigger challenge lies in the constantly changing regulatory environment...

The FDA recently announced it is considering non-invasive surrogate endpoints for clinical trials of treatments for metabolic dysfunction-associated steatohepatitis (MASH). MASH, a severe form of...

If you’ve heard even a little about clinical trials, you’ve likely come across the terms “CRA” and “CRC.” However, it can be confusing to understand exactly what these roles entail and how they...

Clinical trials often face a major hurdle: patient recruitment. Delays in patient enrollment can disrupt timelines and escalate costs, with global data indicating over 80% of trials experience such...

Advanced regenerative bio-law revision marks a transformative shift in Korea’s healthcare landscape, effective February 21, 2025. This guide explores the key changes, focusing on expanded patient...

Developing new drugs is a complex, resource-intensive process requiring significant time and investment. For overseas pharmaceutical companies aiming to penetrate Korea’s thriving market, conducting...

Why Practitioners Need to Know About the Updated Drug Safety Regulations For professionals in the pharmaceutical and biotech industries involved in new drug development, product licensing, clinical...

1. Collecting Real Patient Data The performance of a Wellness AI platform heavily depends on the quantity and quality of its training data. Particularly, AI systems for diagnostic support, prognosis...